Clostridium perfingens bloodstream infections (BSIs) can be associated with high mortality rates. We performed a subanalysis of all C. perfringens BSIs enrolled during a multicentric retrospective observational study (ITANAEROBY). Data were collected from January 2016 to December 2020. C. perfringens BSIs were 134 (134/1960, 6.8 %). The highest resistance rate was observed for clindamycin (26/120, 21.6 %), penicillin (11/71, 15.4 %) and metronidazole (14/131, 10.7 %). In conclusion, C. perfringens reduced susceptibility phenotype to first-line therapy.
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY) / Geremia, Nicholas; Sanson, Gianfranco; Principe, Luigi; Antonello, Roberta Maria; Zerbato, Verena; Luzzati, Roberto; ITANAEROBY study, Group; Maraolo, Alberto Enrico; Giacobbe, Daniele Roberto; Sepulcri, Chiara; Ambretti, Simone; Aschbacher, Richard; Bartolini, Laura; Bernardo, Mariano; Bielli, Alessandra; Busetti, Marina; Carcione, Davide; Camarlinghi, Giulio; Carretto, Edoardo; Cassetti, Tiziana; Chilleri, Chiara; De Rosa, Francesco Giuseppe; Dodaro, Saveria; Gargiulo, Raffaele; Greco, Francesca; Knezevich, Anna; Intra, Jari; Lupia, Tommaso; Concialdi, Erika; Bianco, Gabriele; Luzzaro, Francesco; Mauri, Carola; Morroni, Gianluca; Mosca, Adriana; Pagani, Elisabetta; Parisio, Eva Maria; Ucciferri, Claudio; Vismara, Chiara; Di Bella, Stefano. - In: ANAEROBE. - ISSN 1075-9964. - ELETTRONICO. - 90:(2024), pp. 102901."-"-102901."-". [10.1016/j.anaerobe.2024.102901]
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY)
Sanson, GianfrancoSecondo
;Antonello, Roberta Maria;Zerbato, Verena;Luzzati, RobertoPenultimo
;Busetti, MarinaMembro del Collaboration Group
;Di Bella, StefanoMembro del Collaboration Group
2024-01-01
Abstract
Clostridium perfingens bloodstream infections (BSIs) can be associated with high mortality rates. We performed a subanalysis of all C. perfringens BSIs enrolled during a multicentric retrospective observational study (ITANAEROBY). Data were collected from January 2016 to December 2020. C. perfringens BSIs were 134 (134/1960, 6.8 %). The highest resistance rate was observed for clindamycin (26/120, 21.6 %), penicillin (11/71, 15.4 %) and metronidazole (14/131, 10.7 %). In conclusion, C. perfringens reduced susceptibility phenotype to first-line therapy.| File | Dimensione | Formato | |
|---|---|---|---|
|
GEREMIA A 2024 C perfringens.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
434.4 kB
Formato
Adobe PDF
|
434.4 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
